These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 15816957)

  • 1. Hypersomnia in an epilepsy patient treated with levetiracetam.
    Khatami R; Siegel AM; Bassetti CL
    Epilepsia; 2005 Apr; 46(4):588-9. PubMed ID: 15816957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
    Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF
    Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The acute effects of levetiracetam on nocturnal sleep and daytime sleepiness in patients with partial epilepsy.
    Zhou JY; Tang XD; Huang LL; Zhong ZQ; Lei F; Zhou D
    J Clin Neurosci; 2012 Jul; 19(7):956-60. PubMed ID: 22595355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute psychosis associated with levetiracetam.
    Youroukos S; Lazopoulou D; Michelakou D; Karagianni J
    Epileptic Disord; 2003 Jun; 5(2):117-9. PubMed ID: 12875956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levetiracetam-induced seizure aggravation associated with continuous spikes and waves during slow sleep in children with refractory epilepsies.
    Caraballo RH; Cersósimo R; De los Santos C
    Epileptic Disord; 2010 Jun; 12(2):146-50. PubMed ID: 20483715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures.
    Wu XY; Hong Z; Wu X; Wu LW; Wang XF; Zhou D; Zhao ZX; Lv CZ
    Epilepsia; 2009 Mar; 50(3):398-405. PubMed ID: 18657175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The place of levetiracetam in the treatment of epilepsy.
    Leppik IE
    Epilepsia; 2001; 42 Suppl 4():44-5. PubMed ID: 11564126
    [No Abstract]   [Full Text] [Related]  

  • 8. Catatonia induced by levetiracetam.
    Chouinard MJ; Nguyen DK; Clément JF; Bruneau MA
    Epilepsy Behav; 2006 Feb; 8(1):303-7. PubMed ID: 16249124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of paradoxical levetiracetam effect is increased in mentally retarded patients.
    Szucs A; Clemens Z; Jakus R; Rásonyi G; Fabó D; Holló A; Barcs G; Kelemen A; Janszky J
    Epilepsia; 2008 Jul; 49(7):1174-9. PubMed ID: 18479387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levetiracetam: new preparation. For some patients with refractory partial epilepsy.
    Prescrire Int; 2003 Apr; 12(64):53-4. PubMed ID: 12674114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of levetiracetam in the treatment of Panayiotopoulos syndrome.
    García C; Rubio G
    Epilepsy Res; 2009 Aug; 85(2-3):318-20. PubMed ID: 19423296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levetiracetam in focal epilepsy and hepatic porphyria: a case report.
    Paul F; Meencke HJ
    Epilepsia; 2004 May; 45(5):559-60. PubMed ID: 15101839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levetiracetam: an improvement of attention and of oral fluency in patients with partial epilepsy.
    Piazzini A; Chifari R; Canevini MP; Turner K; Fontana SP; Canger R
    Epilepsy Res; 2006 Mar; 68(3):181-8. PubMed ID: 16332430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of levetiracetam in children younger than 4 years: a retrospective review.
    Perry MS; Benatar M
    Epilepsia; 2007 Jun; 48(6):1123-7. PubMed ID: 17430408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Status gelasticus associated with levetiracetam as add-on treatment.
    Pustorino G; Spano M; Sgro DL; Di Rosa G; Tricomi G; Bellantone D; Tortorella G
    Epileptic Disord; 2007 Jun; 9(2):186-9. PubMed ID: 17525032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral effects and somnolence due to levetiracetam versus oxcarbazepine - a retrospective comparison study of North Indian patients with refractory epilepsy.
    Shukla G; Gupta A; Agarwal P; Poornima S
    Epilepsy Behav; 2016 Nov; 64(Pt A):216-218. PubMed ID: 27756024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The SKATE study: an open-label community-based study of levetiracetam as add-on therapy for adults with uncontrolled partial epilepsy.
    Steinhoff BJ; Somerville ER; Van Paesschen W; Ryvlin P; Schelstraete I
    Epilepsy Res; 2007 Aug; 76(1):6-14. PubMed ID: 17681453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Onset of action of levetiracetam: a RCT trial using therapeutic intensive seizure analysis (TISA).
    Stefan H; Wang-Tilz Y; Pauli E; Dennhöfer S; Genow A; Kerling F; Lorber B; Fraunberger B; Halboni P; Koebnick C; Gefeller O; Tilz C
    Epilepsia; 2006 Mar; 47(3):516-22. PubMed ID: 16529615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyponatremia associated with repeated use of levetiracetam.
    Nasrallah K; Silver B
    Epilepsia; 2005 Jun; 46(6):972-3. PubMed ID: 15946344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial.
    Peltola J; Coetzee C; Jiménez F; Litovchenko T; Ramaratnam S; Zaslavaskiy L; Lu ZS; Sykes DM;
    Epilepsia; 2009 Mar; 50(3):406-14. PubMed ID: 19317886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.